'Dusty core disease' (DuCD): expanding morphological spectrum of RYR1 recessive myopathies.


Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
05 01 2019
Historique:
received: 19 12 2018
accepted: 21 12 2018
entrez: 7 1 2019
pubmed: 7 1 2019
medline: 3 4 2020
Statut: epublish

Résumé

Several morphological phenotypes have been associated to RYR1-recessive myopathies. We recharacterized the RYR1-recessive morphological spectrum by a large monocentric study performed on 54 muscle biopsies from a large cohort of 48 genetically confirmed patients, using histoenzymology, immunohistochemistry, and ultrastructural studies. We also analysed the level of RyR1 expression in patients' muscle biopsies. We defined "dusty cores" the irregular areas of myofibrillar disorganisation characterised by a reddish-purple granular material deposition with uneven oxidative stain and devoid of ATPase activity, which represent the characteristic lesion in muscle biopsy in 54% of patients. We named Dusty Core Disease (DuCD) the corresponding entity of congenital myopathy. Dusty cores had peculiar histological and ultrastructural characteristics compared to the other core diseases. DuCD muscle biopsies also showed nuclear centralization and type1 fibre predominance. Dusty cores were not observed in other core myopathies and centronuclear myopathies. The other morphological groups in our cohort of patients were: Central Core (CCD: 21%), Core-Rod (C&R:15%) and Type1 predominance "plus" (T1P+:10%). DuCD group was associated to an earlier disease onset, a more severe clinical phenotype and a lowest level of RyR1 expression in muscle, compared to the other groups. Variants located in the bridge solenoid and the pore domains were more frequent in DuCD patients. In conclusion, DuCD is the most frequent histopathological presentation of RYR1-recessive myopathies. Dusty cores represent the unifying morphological lesion among the DuCD pathology spectrum and are the morphological hallmark for the recessive form of disease.

Identifiants

pubmed: 30611313
doi: 10.1186/s40478-018-0655-5
pii: 10.1186/s40478-018-0655-5
pmc: PMC6320585
doi:

Substances chimiques

RYR1 protein, human 0
Ryanodine Receptor Calcium Release Channel 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3

Subventions

Organisme : Sapienza Università di Roma
ID : RM116154C9D1415B
Pays : International

Références

Neuropathol Appl Neurobiol. 2011 Apr;37(3):271-84
pubmed: 21062345
Hum Mutat. 2012 Jun;33(6):981-8
pubmed: 22473935
Neurology. 2005 Dec 27;65(12):1930-5
pubmed: 16380615
J Neurol. 2013 Jun;260(6):1504-10
pubmed: 23329375
Neuromuscul Disord. 2009 May;19(5):344-7
pubmed: 19303294
Hum Mutat. 2010 Jul;31(7):E1544-50
pubmed: 20583297
Bioinformatics. 2014 Oct 15;30(20):2981-2
pubmed: 24996895
JAMA Ophthalmol. 2013 Dec;131(12):1532-40
pubmed: 24091937
Am J Med Genet A. 2012 Apr;158A(4):772-8
pubmed: 22407809
Ann Neurol. 2010 Nov;68(5):717-26
pubmed: 20839240
Handb Clin Neurol. 2013;113:1321-36
pubmed: 23622357
Brain. 2007 Aug;130(Pt 8):2024-36
pubmed: 17483490
Neurology. 2013 Apr 23;80(17):1584-9
pubmed: 23553484
Acta Neuropathol. 2017 Apr;133(4):517-533
pubmed: 28012042
Hum Gene Ther. 2013 Jul;24(7):702-13
pubmed: 23805838
Neuromuscul Disord. 2013 Jul;23(7):540-8
pubmed: 23628358
Hum Mutat. 2008 May;29(5):670-8
pubmed: 18253926
Hum Mol Genet. 2003 May 15;12(10):1171-8
pubmed: 12719381
Neuromuscul Disord. 2009 Oct;19(10):721-9
pubmed: 19683444
Hum Mol Genet. 2006 Sep 15;15(18):2791-803
pubmed: 16940308
J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1149-52
pubmed: 24828896
Orphanet J Rare Dis. 2007 Jul 13;2:31
pubmed: 17631035
Muscle Nerve. 2011 Jul;44(1):102-8
pubmed: 21674524
Am J Hum Genet. 2017 Feb 2;100(2):267-280
pubmed: 28132688
Orphanet J Rare Dis. 2013 Aug 06;8:117
pubmed: 23919265
Eur J Neurol. 2015 Jul;22(7):1094-112
pubmed: 25960145
J Neuromuscul Dis. 2015 Nov 20;2(4):421-432
pubmed: 27858745
Neuromuscul Disord. 2010 Apr;20(4):223-8
pubmed: 20181480
Brain. 2003 Nov;126(Pt 11):2341-9
pubmed: 12937085
Proc Natl Acad Sci U S A. 1994 Mar 15;91(6):2270-4
pubmed: 8134386
Eur J Med Genet. 2011 Jan-Feb;54(1):29-33
pubmed: 20888934
Nucleic Acids Res. 2015 Jul 1;43(W1):W174-81
pubmed: 25883148
Neuromuscul Disord. 2017 Nov;27(11):975-985
pubmed: 28818389
Neurology. 2002 Jul 23;59(2):284-7
pubmed: 12136074
Cell. 2016 Sep 22;167(1):145-157.e17
pubmed: 27662087
Neuromuscul Disord. 2016 Sep;26(9):624-33
pubmed: 27377473
Acta Neuropathol Commun. 2016 Nov 17;4(1):121
pubmed: 27855725
Hum Mol Genet. 2000 Nov 1;9(18):2599-608
pubmed: 11063719
Neurology. 2000 Dec 12;55(11):1689-96
pubmed: 11113224
Cell Res. 2016 Sep;26(9):995-1006
pubmed: 27468892
Ann Neurol. 2002 Jun;51(6):750-9
pubmed: 12112081

Auteurs

Matteo Garibaldi (M)

Neuromuscular Morphology Unit, Myology Institute, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France. matteo.garibaldi@uniroma1.it.
Unit of Neuromuscular Diseases, Neuromuscular Disease Centre, Department of Neurology Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, SAPIENZA University of Rome, Sant'Andrea Hospital, Via di Grottarossa 1035-1039, 00189, Rome, Italy. matteo.garibaldi@uniroma1.it.

John Rendu (J)

Centre Hospitalier Universitaire de Grenoble Alpes, Biochimie Génétique et Moléculaire, Grenoble, France.
Grenoble Institut des Neurosciences- Inserm U1216 - UGA, Grenoble, France.

Julie Brocard (J)

Grenoble Institut des Neurosciences- Inserm U1216 - UGA, Grenoble, France.

Emmanuelle Lacene (E)

Neuromuscular Morphology Unit, Myology Institute, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France.

Julien Fauré (J)

Centre Hospitalier Universitaire de Grenoble Alpes, Biochimie Génétique et Moléculaire, Grenoble, France.
Grenoble Institut des Neurosciences- Inserm U1216 - UGA, Grenoble, France.

Guy Brochier (G)

Neuromuscular Morphology Unit, Myology Institute, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France.

Maud Beuvin (M)

Sorbonne Universités UPMC Univ Paris 06- Inserm UMRS974, Center of Research in Myology, Institut de Myologie, Centre de Référence Maladies Neuromusculaire Paris-Est-Ile de France, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.

Clemence Labasse (C)

Neuromuscular Morphology Unit, Myology Institute, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France.

Angeline Madelaine (A)

Neuromuscular Morphology Unit, Myology Institute, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France.

Edoardo Malfatti (E)

Service Neurologie Médicale, Centre de Référence Maladies Neuromusculaire Paris-Est-Ile de France, CHU Raymond-Poincaré Paris Ouest, Garches, France.
U1179 UVSQ-INSERM Handicap Neuromusculaire: Physiologie, Biothérapie et Pharmacologie appliquées, UFR des sciences de la santé Simone Veil, Université Versailles-Saint-Quentin-en-Yvelines, Versailles, France.

Jorge Alfredo Bevilacqua (JA)

Neuromuscular Unit, Department of Neurology and Neurosurgery, University of Chile Clinical Hospital, Santiago, Chile.
Department of Anatomy and Legal Medicine, Faculty of Medicine, University of Chile, Santiago, Chile.

Fabiana Lubieniecki (F)

Servicio de Neurología y Servicio de Patologia, Hospital de Pediatría Garrahan, Buenos Aires, Argentina.

Soledad Monges (S)

Servicio de Neurología y Servicio de Patologia, Hospital de Pediatría Garrahan, Buenos Aires, Argentina.

Ana Lia Taratuto (AL)

Neuropathology, Foundation for Neurological Research (FLENI), Buenos Aires, Argentina.

Jocelyn Laporte (J)

Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), 1, rue Laurent Fries, BP 10142, 67404, Illkirch, France.
INSERM U1258, 67404, Illkirch, France.
CNRS, UMR7104, 67404, Illkirch, France.
Université de Strasbourg, 67404, Illkirch, France.

Isabelle Marty (I)

Grenoble Institut des Neurosciences- Inserm U1216 - UGA, Grenoble, France.

Giovanni Antonini (G)

Unit of Neuromuscular Diseases, Neuromuscular Disease Centre, Department of Neurology Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, SAPIENZA University of Rome, Sant'Andrea Hospital, Via di Grottarossa 1035-1039, 00189, Rome, Italy.

Norma Beatriz Romero (NB)

Neuromuscular Morphology Unit, Myology Institute, Groupe Hospitalier Universitaire La Pitié-Salpêtrière, Paris, France.
Sorbonne Universités UPMC Univ Paris 06- Inserm UMRS974, Center of Research in Myology, Institut de Myologie, Centre de Référence Maladies Neuromusculaire Paris-Est-Ile de France, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH